News | Stroke

July 13, 2018 – iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID ...

Home July 13, 2018
Home
News | Intra-Vascular Ultrasound (IVUS)

Intact Vascular Inc. announced the publication of the iDissection Classification trial results in the current issue of Journal of Invasive Cardiology.

Home July 12, 2018
Home
Technology | Computed Tomography (CT)

Zebra Medical Vision has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Coronary Calcium Scoring algorithm. The algorithm, capable of automatically calculating a patient’s Agatston equivalent coronary calcium score from an electrocardiogram (ECG)-gated computed tomography (CT) scan, provides physicians with important data used in the assessment of the risk for coronary artery disease.

Home July 12, 2018
Home
News | FFR Technologies

CathWorks announced the approval of a new Current Procedural Terminology (CPT) code 0523T for non-invasive, 3-D FFRangio-enabled interpretation of possible atherosclerotic stenosis during coronary angiography interventions. The company said the code issuance is a major step forward in helping physicians objectively and cost-effectively determine if percutaneous coronary intervention (PCI) is indicated and revascularization has occurred in every coronary angiography procedure.

Home July 12, 2018
Home
ICD Placements Not Meeting Medicare Coverage Criteria Decline After Overuse Investigation Announced
Feature | Implantable Cardioverter Defibrillator (ICD)

Placement of implantable cardioverter defibrillators (ICDs) not meeting Centers for Medicare and Medicaid Services (CMS) National Coverage Determination criteria declined following the announcement of a U.S. Department of Justice (DOJ) investigation into potential overuse of such devices. This conclusion was drawn from a recent study of hospitals participating in the NCDR ICD Registry.

Home July 11, 2018
Home
News | Ventricular Assist Devices (VAD)

French-based CorWave announced that its CALYPSO program has received 14 million euros to develop CorWave Neptune, a new type of cardiac support to improve the management of patients with severe heart failure. The CALYPSO Research and Development (R&D) program, with a total budget of 25 million euros over 4 years, will be partially financed with 14 million euros support from the Programme d'Investissements d'Avenir (Future Investments Program), managed by the Secrétariat Général pour l’Investissement (General Secretariat for Investment – SGPI) and operated by Bpifrance.

Home July 11, 2018
Home
The Zoll LifeVest wearable defibrillator was the subject of the VEST Trial
Feature | Defibrillator Monitors | Michael J. Mirro, M.D.

Following the Vest Prevention of Early Sudden Death Trial (VEST) presentation at the 2018 American College of Cardiology ...

Home July 10, 2018
Home
Technology | Transesophageal Echo (TEE)

July 10, 2018 — Evanston, Ill.-based startup Visura Technologies has received 510(k) clearance from the U.S. Food and ...

Home July 10, 2018
Home
Videos | Heart Valve Technology

Ori Ben-Yehuda, M.D., executive director of the Cardiovascular Research Foundation Clinical Trial Center, discusses the ...

Home July 10, 2018
Home
Blog | Cardiovascular Ultrasound

I attended the American Society of Echocardiography (ASE) 2018 meeting in June and have the following takeaways on ...

Home July 10, 2018
Home
Videos | Cardiovascular Ultrasound

DAIC Editor Dave Fornell highlights some of the most innovative new technology on the show floor of the American Society ...

Home July 10, 2018
Home
Videos | Artificial Intelligence

Partho Sengupta, M.D., DM, FACC, FASE, chief division of cardiology, director of cardiac imaging, West Virginia ...

Home July 10, 2018
Home
News | Computed Tomography (CT)

The Intersocietal Accreditation Commission (IAC) recently recognized the University of Tennessee Health Science Center (UTHSC) as the first mobile stroke unit in the world to achieve IAC Computed Tomography (CT) accreditation. A three-year accreditation in the areas of Neurological CT/Acute Stroke and Vascular CTA (Computed Tomography Angiography) was awarded to the UTHSC Mobile Stroke Unit in May 2018.

Home July 09, 2018
Home
Technology | Ultrasound Imaging

South Korea-based Healcerion launched the Sonon 300L wireless handheld ultrasound device to the U.S. market following U.S. Food and Drug Administration (FDA) approval. The Sonon 300L is designed to help primary care providers (PCPs) be more efficient and effective, with instant insight to diagnose or refer a patient to a specialist. The system provides flexible ultrasound technology at less than 1/10 the cost of a traditional ultrasound machine, with a user interface anyone can learn in minutes, according to the company.

Home July 09, 2018
Home
360 Photos | 360 View Photos

A 3-D echo exam using the GE Vivid E95 ultrasound system at the American Society of Echocardiography (ASE) 2018. For ...

Home July 09, 2018
Home
Subscribe Now